Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedGastric cancer was added as a listed condition. The page revision updated to v3.4.2, replacing the previous v3.4.1.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 has been introduced, replacing the previous v3.4.0. This seems to be a system update with no changes to the study content.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check41 days agoChange DetectedThe website footer now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check62 days agoChange DetectedLocations were reorganized into a single 'Locations' section listing California, Minnesota, New Jersey, and Texas, replacing the prior state-specific subsections. A new revision tag v3.3.3 was added.SummaryDifference0.4%

- Check91 days agoChange DetectedRevision history updated: added Revision v3.3.2 and removed Revision v3.2.0.SummaryDifference0.0%

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.